http://communicatebetter.net/pharmacy/cialis) J.P.Morgan Healthcare Conference Update #3
Trading Opportunities-Recovery from Bottom or “Dead Cat” Bounce?
Ariad (ARIA $7.23) is up 8.6% pre-market on revised label announcement of commercial availability of Iclusib. The stock hit a low of $2.15 last quarter after safety concerns were announced on the drug.
Sarepta (SRPT $28) is up 40% since the J.P. Morgan update and study updates this week.The stock was hit on FDA delays.The former high flier hit a high of $55 last quarter then plummeted to a low of $12 in November.
ARIA and SRPT are NOT on our focus list. Update later today.
Other Rayno Life Science movers: ILMN up 8%, RGDX up 1.8% , SGEN up 1.7%.
Watch close today as many stocks have turned down. NASDAQ down 0.65%
PowerShares Dynamic Biotech and Genome ETF